Paper1865548
Monoclonal antibodies to endotoxin. New allies against sepsis?
Bone RC. JAMA, 1991. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Monoclonal antibodies to endotoxin. New allies against sepsis? Papers, record 1865548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1865548
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal | Major topic |
| Endotoxins | Major topic |
| Gram-Negative Bacteria | Major topic |
| Sepsis | Major topic |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 1865542 | A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. | https://conductscience.org/library/papers/1865542 |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22735858 | In vitro and in vivo properties of a fully human IgG1 monoclonal antibody that combats multidrug resistant Pseudomonas aeruginosa. | Int J Mol Med | 2012 | https://conductscience.org/library/papers/22735858 | PubMed |
| 22531443 | The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin. | MAbs | 2012 | https://conductscience.org/library/papers/22531443 | PubMed |
| 12225599 | Endotoxemia in critically ill patients: why a reliable test could be beneficial. | Crit Care | 2002 | https://conductscience.org/library/papers/12225599 | PubMed |
| 11645897 | Delaying approval of a critical drug: safety, efficacy, economics, compassion. | J Med Humanit | 1994 | https://conductscience.org/library/papers/11645897 | PubMed |
| 10146878 | Novel monoclonal antiendotoxin antibody therapy: efficacy at any price? | Pharmacoeconomics | 1993 | https://conductscience.org/library/papers/10146878 | PubMed |
| 7930023 | The HA-1A saga: the scientific and ethical dilemma of innovative and costly therapies. | Intensive Care Med | 1994 | https://conductscience.org/library/papers/7930023 | PubMed |
| 1571053 | Monoclonal antibodies in sepsis and septic shock. | BMJ | 1992 | https://conductscience.org/library/papers/1571053 | PubMed |
| 1379143 | Infectious disease therapy in the 1990s. Where are we heading? | Drugs | 1992 | https://conductscience.org/library/papers/1379143 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1865548
GET https://conductscience.org/api/papers/v1/1865548/authors